Shanghai Yizhong Pharmaceutical Co., Ltd.

¥36.55As of Sun 8 Nov 2026, 12:00 UTC
SSE:688091Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR 11.39%
Div yield —
ROE 4.76%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.31)
PE TTM 107.4
TSR TTM (34.13%)
Mkt cap ¥7.485B
ROIC 6.54%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥45
24.48%
(79.01%)
Hold 6|3|6|7|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.78
0.77
0.80
0.84
6.41%
2.26%
9.08%
9.08%
Revenue¥M
573.2
581.3
606.1
621.1
12.00%
9.36%
10.25%
10.24%
Peers (US$1.122B)
Cap (US$)
PE
1.112B
54.61x
1.094B
—
Capital
TTM
5Y
10Y
Leveragex
0.393
0.043
0.047
EBIT/Intx
0.941
0.089
0.090
Own earn%
232.21
(65.90)
(67.42)
Sh yield%
48.60
25.15
23.90
Owners
Insiders/Inst%
2.15
71.65
Short interest%
3.26
SBC / revenue%
2.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
10–14
$1 testx
—
Incr. ROIC%
15